Verweij P.E.Alastruey-Izquierdo A.Amilon K.Cavling Arendrup M.Armstrong-James D.Bignell E.Boulware D.R.Brandão J.Bromley M.Brown G.D.Buil J.B.Chakrabarti A.Chayakulkeeree M.Chiller T.Chindamporn A.Colombo A.L.Cornely O.A.Dannaoui E.Dufresne P.J.Forastiero A.Gangneux J.P.Giske C.Govender N.P.Gow N.A.R.Guillot J.Harrison T.Hoenigl M.Kontoyiannis D.P.Lass-Flörl C.Le T.Li R.Medina N.Meis J.F.Meletiadis J.Oladele R.O.Ostrosky-Zeichner L.Patel A.K.Perfect J.R.Queiroz-Telles F.Rodriguez-Tudela J.L.Rudramurthy S.M.Salmanton García J.dos Santos A.R.Segal E.Seyedmousavi A.Song Y.Thompson G.R.Vena A.Warris A.Wiederhold N.P.Lackner M.dos Santos A.R.Lass‑Flörl C.Patel A.K.Queiroz‑Telles F.Verweij P.E.Rodriguez‑Tudela J.L.Armstrong‑James D.Mahidol University2026-05-012026-05-012026-01-01Nature Medicine (2026)10788956https://repository.li.mahidol.ac.th/handle/123456789/116466Drug-resistant fungal disease must be addressed in the 2026 update to the Global Action Plan on Antimicrobial ResistanceBiochemistry, Genetics and Molecular BiologyMedicineNoteSCOPUS10.1038/s41591-026-04334-52-s2.0-1050366648431546170X41986735